Biocompatible Hydrogel Implantation for Controlled Tissue Distraction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional distraction histogenesis techniques, particularly periosteal distraction, are cumbersome, painful, and prone to complications such as infections and mobility restrictions due to bulky hardware, and lack precision, making them difficult to use for multidirectional corrections.

Innovation Solution

The use of biocompatible hydrogels and bio-textiles that are inserted between tissue layers to gradually separate tissues, triggering natural tissue regeneration by applying mechanical tension, reducing the need for external devices and minimizing complications.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional external distraction devices are used, then distraction histogenesis can be achieved, but patient comfort deteriorates and device complexity increases

Engineering Contradiction:
Improvedistraction histogenesis effectivenessVSAvoidnumber of external components
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent extracts and eliminates the external distraction devices from the system, replacing them with an internal biocompatible composition that performs the distraction function. The composition is inserted between tissue layers and allows controlled separation without external hardware, thereby reducing device complexity while maintaining distraction histogenesis effectiveness.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The biocompatible composition acts as an intermediary substance between the inner and outer tissue layers. It facilitates controlled tissue separation and regeneration by providing a biocompatible medium that enables gradual distraction without direct mechanical contact from external devices, thus simplifying the overall system.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If traditional distraction devices are used, then tissue separation can be achieved, but infection risk increases

Engineering Contradiction:
Improvetissue regeneration capabilityVSAvoidinfection risk
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent removes external distraction devices that create percutaneous access points and potential infection pathways. By using an internal biocompatible composition alone, the system eliminates the need for external hardware that could introduce bacteria, thereby reducing infection risk while maintaining tissue regeneration capability.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The biocompatible composition is designed as a temporary, biodegradable material that fulfills its distraction function and then is naturally resorbed by the body. This eliminates the need for long-term external devices that pose ongoing infection risks, as the composition disappears after completing its regenerative purpose.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Reliability

If multiple percutaneous sites are used, then distraction can be achieved, but surgery complexity increases

Engineering Contradiction:
Improvedistraction controlVSAvoidnumber of implantation sites
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent merges multiple distraction functions into a single biocompatible composition that can be inserted through one surgical site. The composition simultaneously provides distraction, space creation, and regeneration support across multiple tissue layers without requiring separate implantation sites for each function, thereby reducing surgical complexity.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The biocompatible composition serves multiple functions universally: it acts as a spacer, provides mechanical distraction, creates regenerative space, and potentially delivers growth factors. This multi-functionality eliminates the need for multiple specialized devices and implantation sites, simplifying the surgical procedure while maintaining comprehensive distraction control.

Inventive Principle:
Principle #6Universality (Multi-functionality)

4Reliability

If external distraction components are used, then tissue regeneration can be triggered, but patient mobility is restricted

Engineering Contradiction:
Improvetissue regenerationVSAvoidpatient mobility
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent removes external distraction devices that physically restrict patient movement. By using only an internal biocompatible composition, the system eliminates external hardware that would limit mobility, allowing patients to move freely while the composition continues to facilitate tissue regeneration through controlled distraction.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach reduces patient discomfort, minimizes infection risk, and enhances precision, allowing for controlled tissue growth and regeneration, including bone and soft tissue repair, without the drawbacks of traditional methods.

Implementation Method 1

biocompatible hydrogels and bio-textiles that are inserted between tissue layers to gradually separate tissues

Methodology Applied
Scientific EffectHydrogel expansion: Hydrogel

Data Source

PatentUS20260034055A1Biocompatible compound implantation for distraction histogenesis
Publication Date: 2026.02.05 BIODYNAMIK INC
  • US20260034055A1 patent drawing
  • US20260034055A1 patent drawing
  • US20260034055A1 patent drawing

AI summary

Compositions and methods for distraction histogenesis with a biocompatible hydrogel or bio-textile. A biocompatible hydrogel includes a polymer and a crosslinking agent. The biocompatible hydrogel reaches equilibrium with surrounding fluids in the patient from seven days to twenty-two days after implantation in the patient.